acetylcysteine has been researched along with Labyrinth Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pathak, S; Stern, C; Vambutas, A | 1 |
| Brown, RD; Henley, CM; Kupetz, S; Penny, JE | 1 |
1 review(s) available for acetylcysteine and Labyrinth Diseases
| Article | Year |
|---|---|
Link between functional and morphological changes in the inner ear--functional changes produced by ototoxic agents and their interactions.
Topics: Acetylcysteine; Adult; Aminoglycosides; Aminooxyacetic Acid; Anesthetics; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Aspirin; Child; Chloramphenicol; Cochlea; Cochlear Microphonic Potentials; Diuretics; Drug Synergism; Erythromycin; Evoked Potentials, Auditory; Glycerol; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Sensorineural; Humans; Labyrinth Diseases; Noise; Otitis Media; Rats; Stria Vascularis | 1985 |
1 other study(ies) available for acetylcysteine and Labyrinth Diseases
| Article | Year |
|---|---|
N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients.
Topics: Acetylcysteine; Antioxidants; Autoimmune Diseases; Humans; Interleukin-8; Labyrinth Diseases; Leukocytes, Mononuclear; Molecular Targeted Therapy; Peroxidase; Tumor Necrosis Factor-alpha | 2015 |